Kuros Biosciences AG
Stock Forecast, Prediction & Price Target

Kuros Biosciences AG Financial Estimates

Kuros Biosciences AG Revenue Estimates

Kuros Biosciences AG EBITDA Estimates

Kuros Biosciences AG Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
CHF13.81M
 
N/A
CHF17.98M
 
30.19%
CHF33.56M
 
86.61%
Avg: CHF107.8M
Low: CHF107.8M
High: CHF107.8M
avg. 221.17%
Avg: CHF140.3M
Low: CHF140.3M
High: CHF140.3M
avg. 30.14%
Avg: CHF150M
Low: CHF150M
High: CHF150M
avg. 6.91%
Avg: CHF172.1M
Low: CHF172.1M
High: CHF172.1M
avg. 14.73%
Net Income
 
% change YoY
CHF-7.54M
 
N/A
CHF-14.59M
 
-93.54%
CHF-13.72M
 
5.94%
Avg: CHF5.48M
Low: CHF5.48M
High: CHF5.48M
avg. 139.97%
Avg: CHF11.70M
Low: CHF11.70M
High: CHF11.70M
avg. 113.33%
Avg: CHF0
Low: CHF0
High: CHF0
avg. -100%
Avg: CHF0
Low: CHF0
High: CHF0
avg. 0%
EBITDA
 
% change YoY
CHF-5.29M
 
N/A
CHF-8.84M
 
-67.07%
CHF-10.40M
 
-17.74%
Avg: CHF-65.92M
Low: CHF-65.92M
High: CHF-65.92M
avg. -533.35%
Avg: CHF-85.80M
Low: CHF-85.80M
High: CHF-85.80M
avg. -30.14%
Avg: CHF-91.73M
Low: CHF-91.73M
High: CHF-91.73M
avg. -6.91%
Avg: CHF-105.24M
Low: CHF-105.24M
High: CHF-105.24M
avg. -14.73%
EPS
 
% change YoY
-$0.23
 
N/A
-$0.43
 
-86.95%
-$0.38
 
11.62%
Avg: $0.15
Low: $0.15
High: $0.15
avg. 139.47%
Avg: $0.32
Low: $0.32
High: $0.32
avg. 113.33%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Operating Expenses
 
% change YoY
CHF18.83M
 
N/A
CHF24.21M
 
28.57%
CHF37.12M
 
53.32%
Avg: CHF82.91M
Low: CHF82.91M
High: CHF82.91M
avg. 123.31%
Avg: CHF107.90M
Low: CHF107.90M
High: CHF107.90M
avg. 30.14%
Avg: CHF115.36M
Low: CHF115.36M
High: CHF115.36M
avg. 6.91%
Avg: CHF132.36M
Low: CHF132.36M
High: CHF132.36M
avg. 14.73%

FAQ

What is Kuros Biosciences AG stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 63.32% in 2025-2028.

We have gathered data from N/A analysts. Their low estimate is 5.48M, average is 5.48M and high is 5.48M.

What is Kuros Biosciences AG stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 68.24% in 2025-2028.

We have gathered data from N/A analysts. Their low revenue estimate is CHF107.8M, average is CHF107.8M and high is CHF107.8M.

What is Kuros Biosciences AG stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 63.20% in 2025-2028.

We have gathered data from N/A analysts. Their low earnings per share estimate is $0.15, average is $0.15 and high is CHF0.15.